Clinical trial

Phase IIB Pilot of Atazanavir + Raltegravir

NCT00768989

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE2

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2012-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

AtazanavirDRUG · verified · RxNorm: atazanavir

RaltegravirDRUG · verified · RxNorm: raltegravir

AtazanavirDRUG · verified · RxNorm: atazanavir

RitonavirDRUG · verified · RxNorm: ritonavir

Tenofovir/EmtricitabineDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Merck Sharp & Dohme LLCcollaborator

Mapped research locations

HoustonTexas, United States2 ParisFrance2 New YorkNew York, United States1 CincinnatiOhio, United States1 Washington D.C.District of Columbia, United States1 PhoenixArizona, United States1 OrlandoFlorida, United States1 New HavenConnecticut, United States1 NantesFrance1 Fort WorthTexas, United States1 RosarioSanta Fe Province, Argentina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00768989 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.